The Bar Is High: Evaluating Fit-for-Use Oncology Real-World Data for Regulatory Decision Making

被引:5
|
作者
Lerro, Catherine C. [1 ]
Bradley, Marie C. [2 ]
Forshee, Richard A. [3 ]
Rivera, Donna R. [1 ]
机构
[1] US FDA, Oncol Ctr Excellence, Off Commissioner, Silver Spring, MD USA
[2] US FDA, Ctr Drug Evaluat & Res, Off Med Policy, Silver Spring, MD 20993 USA
[3] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA
来源
关键词
D O I
10.1200/CCI.23.00261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Real-World Evidence for Regulatory Decision-Making: Guidance From Around the World
    Burns, Leah
    Le Roux, Nadege
    Kalesnik-Orszulak, Robert
    Christian, Jennifer
    Hukkelhoven, Mathias
    Rockhold, Frank
    O'Donnell, John
    [J]. CLINICAL THERAPEUTICS, 2022, 44 (03) : 420 - 437
  • [22] External Comparator Groups Derived from Real-world Data Used in Support of Regulatory Decision Making: Use Cases and Challenges
    Gillis Carrigan
    Brian D. Bradbury
    M. Alan Brookhart
    William B. Capra
    Victoria Chia
    Kenneth J. Rothman
    Khaled Sarsour
    Michael D. Taylor
    Jefferey S. Brown
    [J]. Current Epidemiology Reports, 2022, 9 : 326 - 337
  • [23] Landscape review of global real-world data sources for studying medication use in pregnancy and lactation that support regulatory decision making
    Davis, Kourtney
    Yost, Emily
    Brauneis, Jacquelyne
    Krumme, Alexis
    Geldhof, Anja
    Tuck, Astrud
    Sylvester, Shirley
    Ephross, Sara
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [24] External Comparator Groups Derived from Real-world Data Used in Support of Regulatory Decision Making: Use Cases and Challenges
    Carrigan, Gillis
    Bradbury, Brian D.
    Brookhart, M. Alan
    Capra, William B.
    Chia, Victoria
    Rothman, Kenneth J.
    Sarsour, Khaled
    Taylor, Michael D.
    Brown, Jefferey S.
    [J]. CURRENT EPIDEMIOLOGY REPORTS, 2022, 9 (04) : 326 - 337
  • [25] Real-World Evidence to Support EU Regulatory Decision Making-Results From a Pilot of Regulatory Use Cases
    Prilla, Stefanie
    Groeneveld, Sophie
    Pacurariu, Alexandra
    Restrepo-Mendez, Maria Clara
    Verpillat, Patrice
    Torre, Carla
    Gartner, Christian
    Mol, Peter G. M.
    Naumann-Winter, Frauke
    Breen, Kieran C.
    Gault, Nathalie
    Gross-Martirosyan, Liana
    Benchetrit, Sylvie
    Aylward, Brian
    Stoyanova-Beninska, Violeta
    O'Donovan, Maura
    Straus, Sabine
    Kjaer, Jesper
    Arlett, Peter
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024,
  • [26] Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making
    Wessel, Didrik
    Pogrebnyakov, Nicolai
    [J]. DRUG SAFETY, 2024, 47 (05) : 495 - 511
  • [27] Transferability of real-world data across borders for regulatory and health technology assessment decision-making
    Jaksa, Ashley
    Arena, Patrick J.
    Chan, Kelvin K. W.
    Ben-Joseph, Rami H.
    Jonsson, Pall
    Campbell, Ulka B.
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [28] Contributions of Real-World Evidence and Real-World Data to Decision-Making in the Management of Soft Tissue Sarcomas
    Demetri, George D.
    Stacchiotti, Silvia
    [J]. ONCOLOGY, 2021, 99 (SUPPL 1) : 3 - 7
  • [29] Evaluating eligibility criteria of oncology trials using real-world data and AI
    Liu, Ruishan
    Rizzo, Shemra
    Whipple, Samuel
    Pal, Navdeep
    Pineda, Arturo Lopez
    Lu, Michael
    Arnieri, Brandon
    Lu, Ying
    Capra, William
    Copping, Ryan
    Zou, James
    [J]. NATURE, 2021, 592 (7855) : 629 - +
  • [30] Real-world evidence for regulatory decision-making: updated guidance from around the world
    Burns, Leah
    Le Roux, Nadege
    Kalesnik-Orszulak, Robert
    Christian, Jennifer
    Dudinak, Jennifer
    Rockhold, Frank
    Khozin, Sean
    O'Donnell, John
    [J]. FRONTIERS IN MEDICINE, 2023, 10